Menu
Menu
Aurobindo Pharma's Telangana facility recently underwent an FDA inspection, resulting in two procedural observations. While these observations are not related to product quality, the company plans to address them promptly. In the meantime, Aurobindo continues to show strong financial performance, driven by sales growth in key markets like Europe and the U.S.
In a significant stride forward, Alembic Pharmaceuticals has secured USFDA approval for its Doxycycline Capsules, 40 mg, a pivotal development in dermatological care. This approval underscores Alembic's commitment to providing effective treatment options for rosacea, addressing inflammatory lesions with a therapeutically equivalent alternative. Explore how this milestone not only expands Alembic's portfolio but also enhances accessibility to quality healthcare solutions.